Literature DB >> 8435838

Thermal laser-assisted angioplasty of renal artery stenosis for renovascular hypertension.

M Tani1, K Mizuno, H Midorikawa, T Igari, M Egawa, S Niimura, S Fukuchi, S Hoshino.   

Abstract

Percutaneous transluminal laser-assisted angioplasty of a renal artery stenosis was performed in a 16-year-old woman with renovascular hypertension. The stenotic portion of the renal artery was predilated by delivering Nd-YAG laser energy to the terminal tip of a laser catheter. Although the luminal diameter did not increase sufficiently with laser angioplasty alone, it allowed passage of the balloon catheter and subsequent successful balloon angioplasty. Immediately after dilatation, the patient's blood pressure fell to normal, and plasma renin activity decreased. There were no serious complications. Thermal laser angioplasty seems to be an effective adjunct technique for the treatment of severe renal artery stenosis which does not allow initial passage of a balloon catheter.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435838     DOI: 10.1007/bf02603039

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  10 in total

1.  Angiographic and histologic consequences of laser thermal angioplasty: comparison with balloon angioplasty.

Authors:  T A Sanborn; C C Haudenschild; G R Garber; T J Ryan; D P Faxon
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

2.  Percutaneous transluminal laser angioplasty in man.

Authors:  H Geschwind; G Boussignac; B Teisseire; C Vieilledent; A Gaston; J P Becquemin; P Mayiolini
Journal:  Lancet       Date:  1984-04-14       Impact factor: 79.321

3.  Percutaneous transluminal angioplasty. Council on Scientific Affairs.

Authors: 
Journal:  JAMA       Date:  1984-02-10       Impact factor: 56.272

4.  Experimental angioplasty: circumferential distribution of laser thermal energy with a laser probe.

Authors:  T A Sanborn; D P Faxon; C C Haudenschild; T J Ryan
Journal:  J Am Coll Cardiol       Date:  1985-04       Impact factor: 24.094

5.  Percutaneous transluminal renal angioplasty in nonatherosclerotic renovascular hypertension. Long-term results.

Authors:  V G Millan; J McCauley; R I Kopelman; N E Madias
Journal:  Hypertension       Date:  1985 Sep-Oct       Impact factor: 10.190

6.  Percutaneous transluminal laser angioplasty for treatment of peripheral vascular disease. Clinical experience with 16 patients.

Authors:  R Ginsburg; L Wexler; R S Mitchell; D Profitt
Journal:  Radiology       Date:  1985-09       Impact factor: 11.105

7.  Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia.

Authors:  T A Sos; T G Pickering; K Sniderman; S Saddekni; D B Case; M F Silane; E D Vaughan; J H Laragh
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

8.  Percutaneous transluminal renal angioplasty in management of atherosclerotic renovascular hypertension: results in 100 patients.

Authors:  V J Canzanello; V G Millan; J E Spiegel; P S Ponce; R I Kopelman; N E Madias
Journal:  Hypertension       Date:  1989-02       Impact factor: 10.190

9.  Percutaneous laser thermal angioplasty: initial clinical results with a laser probe in total peripheral artery occlusions.

Authors:  D C Cumberland; T A Sanborn; D I Tayler; D J Moore; C L Welsh; A J Greenfield; J K Guben; T J Ryan
Journal:  Lancet       Date:  1986-06-28       Impact factor: 79.321

10.  Laser recanalization of occluded atherosclerotic arteries in vivo and in vitro.

Authors:  G S Abela; S J Normann; D M Cohen; D Franzini; R L Feldman; F Crea; A Fenech; C J Pepine; C R Conti
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

  10 in total
  1 in total

Review 1.  Treatment of severe renal artery stenosis by percutaneous transluminal renal angioplasty and stent implantation: review of the pediatric experience: apropos of two cases.

Authors:  Kai König; Jutta Gellermann; Uwe Querfeld; Martin B E Schneider
Journal:  Pediatr Nephrol       Date:  2006-03-07       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.